anti-7-Ketocholesterol [7-KC], mAb (35A)
792 CHF CHF 792.00
JAI-MKC-020N20 µgCHF 792.00
Figure 1: Immunohistochemical staining of 7KC in atherosclerotic aorta using anti-7-KC, mAb (35A).
|Product Type||Monoclonal Antibody|
|Immunogen/Antigen||7-KC-modified keyhole-lympet hemocyanine.|
|Application||Immunohistochemistry: Recommended concentration is 5-10μg/mL on frozen sections.|
|Purity Detail||Protein A purified.|
|Formulation||Frozen liquid. Contains 10mM PBS, 0.1% NaN3 and 0.5% BSA.|
|Other Product Data||
Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.
|Declaration||Manufactured by JaICA.|
|Shipping and Handling|
|Short Term Storage||+4°C|
|Long Term Storage||-20°C|
|Handling Advice||Avoid freeze/thaw cycles.|
|Use/Stability||Stable for at least 3 years after receipt when stored at -20°C.|
|Product Specification Sheet|
Cholesterol oxidation products, especially 7-Ketocholesterol (7KC), have been the focus of much attention because they are present in human atherosclerotic plaque and display a wide range of atherogenic properties in vitro and to some extant in vivo.
- Oxysterol mixtures, in atheroma-relevant proportions, display synergistic and proapoptotic effects: D.A. Larsson, et al.; Free Rad. Biol. Med. 41, 902 (2006)